This site is intended for US healthcare professionals. For patient resources and support, click here indication
Biomarkers
Biomarker testing can make a difference
Testing for biomarkers can shed light on how a patient's cancer might behave, help identify potential treatment and clinical trial options, and support informed decision-making with your patients.1
As a busy healthcare provider, you may not always have time to research relevant biomarker information for each case. So use the information below to help you find what you need.
Explore biomarker resources with ease
Download a handy reference of biomarkers from the NCCN Guidelines®
Refer to this guide for information on biomarkers and their respective testing options across the most common solid tumor types.
Use this tool to review biomarker information for specific tumor types
Bladder cancer biomarkers1
FGFR3=fibroblast growth factor receptor 3, HER2=human epidermal growth factor receptor 2, IHC=immunohistochemistry.
NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in anyway.
Last updated on April 28, 2026.
Reference:
- Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Bladder Cancer v2.2026. © National Comprehensive Cancer Network, Inc. 2026. All rights reserved. Accessed April 28, 2026. To view the most recent and complete version of the guideline, go online to NCCN.org.
Stay on top of the latest NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
Explore NCCN Guidelines® new NCCN Guidelines Navigator™
Access this interactive digital tool to easily search and navigate the NCCN Guidelines.2
Subscribe to NCCN Guidelines NCCN Flash Updates™
You'll get updates on a range of NCCN Guidelines resources sent directly to your inbox.3
Precision medicine resources for nurse navigators
Guiding nurse navigators through the precision medicine pathway
This tool is intended to help support nurse navigators build upon their knowledge of precision medicine and its potential impact on treatment decision-making throughout the cancer journey.
Patient navigator precision medicine cancer resource guide
This tool is intended to help oncology nurse and patient navigators to achieve patient-centered superior quality cancer care coordination from pre-diagnosis through survivorship/end of life.
Biomarker testing may allow for guided therapy that can prevent unnecessary treatments and costs
*Based on a September 2023 web-based survey that explored experiences with biomarker testing of 1222 cancer patients and survivors nationwide who have been diagnosed with or treated for cancer in the last 7 years.6
With biomarkers, knowledge is power
Biomarker testing looks different for every cancer, so knowing which steps to take is important. Visit the sites below to see some ways Pfizer is raising awareness about individual biomarkers and how to test for them.
The Blind Spot podcast
Listen to the first episode, "The convergence of technology and biology with Dr. Nadine Jackson," and learn about the changing oncology landscape and the role biomarkers play in emerging treatment.
Help your patients get the answers they need
Our customizable discussion guide creator helps patients have more focused conversations about biomarkers with their healthcare team.
Precision medicine pathway
This roadmap is intended to help patients with cancer learn more about precision medicine, what to expect from it, and how it may help a patient's care team recommend the best treatment for them.
References:
- This is living with cancer: biomarker testing in cancer treatment. Accessed April 28, 2026. https://www.thisislivingwithcancer.com/understanding-cancer/genetic-testing
- NCCN guidelines navigator. Accessed April 28, 2026. https://www.nccn.org/guidelines/nccn-guidelines-navigator
- NCCN flash updates. Accessed April 28, 2026. https://www.nccn.org/business-policy/business/flash-updates
- Cancer patients and survivors overwhelmingly agree biomarker testing improved Their Treatment. Accessed April 28, 2026. https://www.fightcancer.org/policy-resources/cancer-patients-and-survivors-overwhelmingly-agree-biomarker-testing-improved-their
- Increasing access to biomarker testing. Accessed April 28, 2026 https://www.fightcancer.org/increasing-access-biomarker-testing-0
- Survivor views: biomarker testing September 2023. Accessed April 28, 2026. https://www.fightcancer.org/sites/default/files/national_documents/survivorviews_biomarkers.pdf